RABEPRAZOLE EC DIN 02356538
Health Canada record
| Active ingredient(s) | RABEPRAZOLE SODIUM 20 MG |
|---|---|
| Dosage form | Tablet (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A02BC04 RABEPRAZOLE |
| Original market date | 23-Nov-2010 |
| Current status date | 30-May-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RABEPRAZOLE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02484161 | AG-RABEPRAZOLE | ANGITA PHARMA INC. | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Approved |
| 02484188 | AG-RABEPRAZOLE | ANGITA PHARMA INC. | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Approved |
| 02243796 | PARIET, ENTERIC-COATED TABLET 10MG | JANSSEN INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Marketed |
| 02243797 | PARIET, ENTERIC-COATED TABLET 20MG | JANSSEN INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Marketed |
| 02385449 | RABEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Marketed |
| 02385457 | RABEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Marketed |
| 02356511 | RABEPRAZOLE EC | SANIS HEALTH INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Marketed |
| 02314177 | SANDOZ RABEPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Marketed |
| 02314185 | SANDOZ RABEPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Marketed |
| 02419793 | TARO-RABEPRAZOLE EC | SUN PHARMA CANADA INC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Approved |
| 02419785 | TARO-RABEPRAZOLE EC | SUN PHARMA CANADA INC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Approved |
| 02422638 | ABBOTT-RABEPRAZOLE | BGP PHARMA ULC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02422646 | ABBOTT-RABEPRAZOLE | BGP PHARMA ULC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02345579 | APO-RABEPRAZOLE | APOTEX INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02345587 | APO-RABEPRAZOLE | APOTEX INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02320460 | DOM-RABEPRAZOLE EC | DOMINION PHARMACAL | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02320452 | DOM-RABEPRAZOLE EC | DOMINION PHARMACAL | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Pre Market |
| 02415291 | JAMP RABEPRAZOLE | JAMP PHARMA CORPORATION | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Dormant |
| 02415283 | JAMP RABEPRAZOLE | JAMP PHARMA CORPORATION | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Dormant |
| 02408406 | MYLAN-RABEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02408392 | MYLAN-RABEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02345994 | NTP-RABEPRAZOLE EC | NT PHARMA CANADA LTD | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Cancelled Pre Market |
| 02346001 | NTP-RABEPRAZOLE EC | NT PHARMA CANADA LTD | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Cancelled Pre Market |
| 02381737 | PAT-RABEPRAZOLE | PATRIOT A DIVISION OF JANSSEN INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02381745 | PAT-RABEPRAZOLE | PATRIOT A DIVISION OF JANSSEN INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02310805 | PMS-RABEPRAZOLE EC | PHARMASCIENCE INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Dormant |
| 02310813 | PMS-RABEPRAZOLE EC | PHARMASCIENCE INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Dormant |
| 02315203 | PRO-RABEPRAZOLE | PRO DOC LIMITEE | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02315181 | PRO-RABEPRAZOLE | PRO DOC LIMITEE | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02320614 | RABEPRAZOLE EC | MELIAPHARM INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02320622 | RABEPRAZOLE EC | MELIAPHARM INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02330091 | RIVA-RABEPRAZOLE EC | LABORATOIRE RIVA INC. | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02330083 | RIVA-RABEPRAZOLE EC | LABORATOIRE RIVA INC. | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02298074 | TARO-RABEPRAZOLE | SUN PHARMA CANADA INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
| 02298082 | TARO-RABEPRAZOLE | SUN PHARMA CANADA INC | Tablet (Enteric-Coated) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02296640 | TEVA-RABEPRAZOLE EC | TEVA CANADA LIMITED | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 20 MG | Cancelled Post Market |
| 02296632 | TEVA-RABEPRAZOLE EC | TEVA CANADA LIMITED | Tablet (Delayed-Release) | RABEPRAZOLE SODIUM 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16135 | 2014-09-26 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
| 15855 | 2014-07-21 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
| 11854 | 2010-11-08 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |
International API supply for RABEPRAZOLE SODIUM
1 valid EDQM Certificates of Suitability from 1 holders. 16 active FDA Drug Master Files.
Request a quote for RABEPRAZOLE EC